Valsartan Tablet, Film Coated
Product Images NDC 31722-154

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 31722-154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Valsartantab160mg-30'scount (Valsartantab160mg 30scount)

Label for Valsartan tablets, USP by Camber Pharmaceuticals, Inc. The film-coated tablets contain 160 mg of Valsartan. The label includes storage instructions, dosage advisory to see package insert, and a quantity of 30 tablets. It features batch coding information, manufacture details, barcode, and U.S. contact number.*

FDA Label Image

Valsartantab160mg-carton (Valsartantab160mg Carton)

Packaging label for Valsartan Tablets, USP 160 mg film-coated oral tablets. The label displays the product name, strength, and dosage form prominently. It indicates the package contains 100 unit dose tablets (10 x 10) and is labeled for prescription use only. Manufactured for Camber Pharmaceuticals, Inc., with additional manufacturing information from Hetero Labs Limited, India. Storage instructions and patient contact information are also included.*

FDA Label Image

Valsartantab320mg-30'scount (Valsartantab320mg 30scount)

Label for Valsartan Tablets, USP 320 mg film-coated tablets by Camber Pharmaceuticals, Inc. The label shows a 30-tablet count with storage and handling instructions, manufacturer information including a license and batch coding area, and a barcode. The product is designated Rx only.*

FDA Label Image

Valsartantab320mg-carton (Valsartantab320mg Carton)

Packaging label for Valsartan Tablets, USP 320 mg film-coated oral tablets, manufactured for Camber Pharmaceuticals, Inc. The package contains 100 unit dose tablets (10 x 10). The label includes storage instructions, manufacturer and distributor details, and a barcode. Strength, dosage form, and labeler name are prominently displayed.*

FDA Label Image

Valsartantab40mg-30'scount (Valsartantab40mg 30scount)

Label for Valsartan Tablets USP 40 mg, film-coated tablets, 30 count. The label shows the manufacturer as Camber Pharmaceuticals, Inc. Storage instructions, dosage guidance to see package insert, and a U.S. contact number are also included. The label features a barcode and mentions manufacturing by Hetero Labs Limited, India.*

FDA Label Image

Valsartantab40mg-carton (Valsartantab40mg Carton)

Packaging label for Valsartan Tablets, USP 40 mg, film coated tablets in a unit dose package of 100 (10 x 10) tablets. The label shows the Camber Pharmaceuticals, Inc. logo and indicates Rx only. Storage and dosage instructions are briefly noted, along with contact information and manufacturing details for Hetero Labs Limited, India.*

FDA Label Image

Valsartantab80mg-30'scount (Valsartantab80mg 30scount)

Label for Valsartan Tablets, USP 80 mg by Camber Pharmaceuticals, Inc. The film-coated tablets are supplied in a package of 30. The label includes storage instructions, a barcode, manufacturer and distributor information, and the U.S. contact number for patient information.*

FDA Label Image

Valsartantab80mg-carton (Valsartantab80mg Carton)

Packaging label for Valsartan Tablets, USP 80 mg film coated tablets by Camber Pharmaceuticals, Inc. The label indicates a unit dose package containing 100 tablets (10 x 10). Storage instructions include protecting from moisture and keeping at controlled room temperature (20° to 25°C). Manufacturer information lists Camber Pharmaceuticals, Inc. in Piscataway, NJ and Hetero Labs Limited in India.*

FDA Label Image

Valsartantabfig1 (Valsartantabfig1)

A subgroup forest plot comparing Valsartan versus Captopril across patient demographics and characteristics, showing patient percentages and confidence intervals for outcomes favoring either Valsartan or Captopril. Subgroups include age (<65, ≥65 years), sex, race, geographic location, and beta-blocker use.*

FDA Label Image

Valsartantabstructure (Valsartantabstructure)

Chemical structure of valsartan, the active ingredient in the Valsartan oral tablet. The diagram depicts the molecular arrangement of atoms and bonds characteristic of valsartan.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.